Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Marshall Hospital partners with UC Davis Health

January 07, 2022
Vol.48 No.01
Clinical Roundup

Black women more likely to develop lymphedema following breast cancer treatment than white women

December 10, 2021
Vol.47 No.45
Cancer centers establish DEI Network as NCI issues CCSG guidelines to enhance diversity in the oncology workforce
Health Equity

Cancer centers establish DEI Network as NCI issues CCSG guidelines to enhance diversity in the oncology workforce

December 03, 2021
Vol.47 No.44
By Matthew Bin Han Ong
DEI Network founders: Let’s work together to increase diversity across all cancer centers in America
Conversation with The Cancer LetterHealth Equity

DEI Network founders: Let’s work together to increase diversity across all cancer centers in America

December 03, 2021
Vol.47 No.44
By Matthew Bin Han Ong
To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria
Guest EditorialHealth Equity

To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria

November 19, 2021
Vol.47 No.43
By Julia Beaver, Thomas S. Uldrick, Gwynn Ison, Suanna S. Bruinooge, Caroline Schenkel and Edward S. Kim
In Brief

Bridget Oppong named deputy director of Ohio State’s Center for Cancer Health Equity

November 19, 2021
Vol.47 No.43
Project Equity: FDA considers options to increase diverse enrollment in clinical trials
FreeHealth Equity

Project Equity: FDA considers options to increase diverse enrollment in clinical trials

November 12, 2021
Vol.47 No.42
By Matthew Bin Han Ong
FDA’s Lola Fashoyin-Aje: Stop getting stuck on the “risks” of diversity in drug development, it’s time to fix disparities in access
Conversation with The Cancer LetterFreeHealth Equity

FDA’s Lola Fashoyin-Aje: Stop getting stuck on the “risks” of diversity in drug development, it’s time to fix disparities in access

November 12, 2021
Vol.47 No.42
By Matthew Bin Han Ong
NCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives
Conversation with The Cancer LetterFreeHealth Equity

NCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives

November 12, 2021
Vol.47 No.42
By Matthew Bin Han Ong
Walter Lawrence, cancer surgeon and civil rights hero, dies at 96
FreeObituary

Walter Lawrence, cancer surgeon and civil rights hero, dies at 96

November 12, 2021
Vol.47 No.42
By Robert A. Winn and Gordon D. Ginder

Posts navigation

Previous1…252627…29Next

Trending Stories

  • Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
  • Pam Bondi diagnosed with thyroid cancer
  • The story of daraxonrasib is the ultimate hero’s journey
    A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
  • At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account